Fifth Third Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Fifth Third Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$646K	Buy	7,136 +1,465	+26%	+$123K	0.02%	410
2026 Q1	$454K	Buy	5,671 +636	+13%	+$52.4K	0.02%	461
2025 Q4	$429K	Sell	5,035 -243	-5%	-$19.9K	0.02%	442
2025 Q3	$410K	Sell	5,278 -131	-2%	-$10.2K	0.02%	446
2025 Q2	$423K	Sell	5,409 -287	-5%	-$21.4K	0.02%	409
2025 Q1	$413K	Buy	5,696 +112	+2%	+$8.02K	0.02%	383
2024 Q4	$413K	Buy	5,584 +278	+5%	+$19.5K	0.02%	384
2024 Q3	$350K	Sell	5,306 -493	-9%	-$35.8K	0.02%	406
2024 Q2	$536K	Buy	+5,799	New	+$514K	0.04%	257

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Fifth Third Wealth Advisors's EW Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its Edwards Lifesciences (EW) stake by 26% in Q2 2026, buying an estimated $123K and bringing the position to 7,136 shares worth $646K. The position accounts for 0.02% of the portfolio, ranked #410.

Fifth Third Wealth Advisors first reported a position in EW in Q2 2024 and has held it in 9 quarters since. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Fifth Third Wealth Advisors held 7,136 shares of Edwards Lifesciences worth $646K as of Q2 2026.
Fifth Third Wealth Advisors bought 1,465 Edwards Lifesciences shares in Q2 2026, an estimated $123K.
Edwards Lifesciences made up 0.02% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #410 holding.
Fifth Third Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 9 quarters since.
265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.